Source: Beyond Medical Technologies Inc.
  • Beyond Medical Technologies (DOCT) has provided an update on its medical face mask manufacturing subsidiary Micron Technologies Inc. 
  • Beyond Medical is considering terminating its mask manufacturing business in response to declining demand
  • The company is interested in investigating business opportunities that can offer attractive shareholder returns and growth opportunities
  • Beyond Medical is an industrial/technology company with a manufacturing facility located in Delta, B.C.
  • The company’s subsidiary Micron Technologies, manufactures medical-grade facemasks
  • Beyond Medical Technologies Inc. (DOCT) opened trading at C$0.035 per share

Beyond Medical Technologies (DOCT) has provided an update on its medical face mask manufacturing subsidiary Micron Technologies Inc. 

With the demand for face masks rapidly declining, Beyond Medical is considering operating Micron Technologies’ facility at reduced capacity or potentially terminating its mask manufacturing business.

Kal Malhi, Beyond Medical’s C.E.O. commented,

“The company is interested in investigating business opportunities in sectors which can offer attractive shareholder returns and offer growth opportunities with the infusion of capital. We are currently reviewing several opportunities and will provide updates as our investigations progress. We cannot, however, provide any assurance the company will successfully identify, secure and fund an agreement to purchase either a business or asset on favorable terms or at all.”

Kal added, “The company welcomes submissions of any opportunities from entrepreneurs and institutional investors where the company’s current capital and ability to raise additional capital can leverage growth for a business.”

Beyond Medical is an industrial/technology company with a manufacturing facility located in Delta, British Columbia. The company, through its subsidiary Micron Technologies, manufactures medical-grade facemasks.

Beyond Medical Technologies Inc. (DOCT) opened trading at C$0.035 per share.

More From The Market Online

Telo Genomics and Emery Pharma collaborate

Telo Genomics (TSXV:TELO) collaborates with Emery Pharma to enhance cellular and molecular bioanalytical solutions for clinical research.

New government funding coming for Canada’s first commercial space port

Maritime Launch Services (NEO:MAXQ) announces a pivotal step forward in the development of Canada’s first commercial orbital spaceport.

The art of taking a flyer: How to play the latest meme stock rally

Roaring Kitty helps push meme stocks such as GameStop (NYSE:GME) and AMC Entertainment (NYSE:AMC) up by as much as 300 per cent since Friday.